drag_handle
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Start a free trial chevron_right
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Does Stem Cell Culture Supernatant Affect the Skin Microbiome? Investigation Results
ReU Inc. (Headquarters: Chuo-ku, Tokyo; President: Natsuhi Ueno), which offers various services utilizing ReU Culture Medium (hereinafter referred to as “culture supernatant”), a human stem cell culture supernatant, investigated the effects of the culture supernatant—manufactured and purified at domestic partner laboratories—on the skin microbiome to verify its efficacy.
Domestic startup developing plant-based egg alternatives
In recent years, the environment surrounding chicken eggs has undergone significant changes, including supply shortages and price surges due to the spread of avian influenza, as well as strengthened animal welfare regulations in regions like the EU. For manufacturers of processed egg products, such as confectionery and bakery goods, stabilizing raw material procurement and addressing sustainability have become urgent challenges. UMAMI UNITED, with its mission of “Creating the Future at ONE TABLE,” has achieved steady growth through its unique approach: providing plant-based eggs with optimized functionality tailored to the specific needs of food businesses. Since our previous investment, the company has successfully pivoted its strategy from full substitutes to function-specific products. By building a recipe library categorized by application, it has established a robust system for accumulating R&D knowledge. We have made an additional investment in this Pre-Series A round, following our seed round, to support UMAMI UNITED's egg functionality library, its ability to solve customer challenges using this library, and its potential to pioneer a sustainable food future.
Solid-State Fermentation: The Technology that Turns Waste into Super Ingredients for Aquafeed
The aquaculture industry, which is essential for global food security, faces a sustainability dilemma: dependence on ingredients such as fishmeal and soya bean meal. However, in recent years, technological advancements and pioneering research breakthroughs are putting into practice a promising biotechnological solution: Solid-State Fermentation. This ancient technique, used in food like bread and beer, is being refined to transform waste inot a new ingredient of high nutritional value for fish. According to experts, Solid-State Fermentation is not only sustainable but is set to revolutionise aquafeed thanks to three specific points that make it a high-impact solution.
An AI medical device that diagnoses COVID-19 using throat images has obtained regulatory approval.
Iris Corporation (Headquarters: Chuo-ku, Tokyo; President: Sho Okiyama; hereinafter “the Company”) announces that it has developed an AI diagnostic tool targeting COVID-19 and that this AI (hereinafter “the new feature”) received regulatory approval on October 2, 2025. This new feature is the one for which the Company submitted an approval application to the government last December*1. This press release reports that this new feature has become the first* AI medical device in Japan to receive medical device approval for diagnosing COVID-19 using throat photographs.
Bifidobacteria in Oil: A Convenient Liquid Probiotic Supplement
・Newly launched on the Naturecan official website: Bifiora lactic acid bacteria oil ・Get your bifidobacteria in oil form! A new liquid-type probiotic supplement ・Features Bifidobacterium BB536 that ‘reaches the gut alive’ ・Unscented and tasteless for easy, refreshing daily support
Functional food with skin elasticity claims using ethyl α-D-glucoside (α-EG) as the functional ingredient has been notified.
Our company has newly demonstrated that ingesting “α-EG,” a component found in Japanese sake, helps maintain the elasticity of the hands and skin in individuals experiencing age-related loss of skin elasticity. We have submitted a notification for a functional food with “α-EG” as a new functional ingredient, which was made public on October 15, 2025. Our Research Institute has long demonstrated that α-EG promotes cell proliferation and collagen production in human skin fibroblasts, and improves skin hydration and rough skin when applied topically. This time, we created a systematic review (SR) based on human oral consumption trial data conducted by an external institution and submitted the notification.
Can Cultivated Marine Supplements Plug the Alt-Seafood Nutrition Gap?
Singaporean food tech startup Umami Bioworks has launched a line of cell-cultured marine supplements to address nutritional deficiencies in non-seafood consumers. Despite consumer concerns about overfishing and the environmental implications of conventional seafood, fish-free alternatives still make up just 1% of this industry. Nutrition is a major reason. Vegan and vegetarian seafood analogues tend to have a lower protein, vitamin B12, and omega-3 content, and experts have called for a diversification of sources and greater micronutrient fortification to truly build consumer uptake. For instance, most seafood alternatives that contain omega-3 fatty acids source them from alpha-linolenic acid, which converts poorly into eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Swedish Cytely raises €3 million to make “smart microscopy” the new standard in science
Lund-based deeptech startup Cytely has raised €3 million in a round led by Ugly Duckling Ventures, with participation from existing investor Icebreaker.vc, to expand access to its smart-microscopy platform. Cytely turns ordinary microscopes into real-time data engines, eliminating manual bottlenecks and allowing labs to generate statistically powered results in minutes instead of months. Already adopted at Lund University and other leading research institutions worldwide, the platform helps scientists quantify complex cellular phenomena — from viral latency to cancer research — with unprecedented speed and accuracy. The fresh funding will be used to enhance Cytely’s intelligent acquisition tools, broaden compatibility with microscope brands, and develop one-click quantitative workflows that make data-centric discovery accessible to every lab. The company’s broader goal is to build a global discovery network where researchers can share validated methods, re-analyze datasets, and accelerate breakthroughs in human biology and disease prevention.
Next-generation ventilator featuring integrated turbine design eliminates need for air piping connections Delivers both lightweight construction and extended operating time
Nihon Kohden Corporation has launched its first turbine-driven, tracheal-intubation ventilator, the NKV-440 Series, in the domestic market. Developed and manufactured by Nihon Kohden OrangeMed in California, USA, this marks its introduction to the Japanese market following its launch in emerging markets in 2022 and the US market in 2024. This product represents one outcome of the company's mid-term management plan established in 2017, prior to the COVID-19 pandemic, which emphasized strengthening ventilator development. While inheriting the operability and functions of the “NKV-550 Series” (which received expedited approval in 2020), it adopts turbine drive technology, eliminating the need for air tubing and enabling use in environments without air supply equipment. Furthermore, its compact, lightweight design and replaceable long-duration battery allow flexible use not only in ERs and ICUs but also in general wards and for in-hospital transport. Based on the “Seamless Care” concept, it accommodates a wide range of patients from neonates (optional) to adults. It enables both invasive and non-invasive ventilation and high-flow therapy with a single unit, while also supporting lung protection strategies via the “Gentle Lung Suite” (optional). The internal turbine incorporates a HEPA filter and achieves approximately 5 hours of operation without compressed air piping. It features an intuitive UI, similar to a smartphone, enhancing operability and workflow efficiency. Priced at ¥8.14 million (including tax; ¥7.4 million before tax), the company aims to sell over 140 units within the next three years. Nihon Kohden intends to improve hospital workflows and enhance the quality of patient care through this new model, which offers high mobility without piping.
New nanotechnology drug reduces amyloid beta in mouse brains by 50 to 60 percent
While scientists still do not know what exactly causes Alzheimer’s disease, previous research shows there are a number of potential factors. A new study explains how a research team was able to use a new nanotechnology strategy to reverse Alzheimer’s disease in mice with the condition. The new nanotechnology helped reduce amyloid-beta in the mice’s brains by 50-60%.
Clean Food Group’s fermentation-derived oil approved for cosmetic use in the UK, Europe and USA
British start-up Clean Food Group (CFG)’s fermentation-derived oil has been approved for cosmetic use in the UK, Europe and the USA. The approval marked a major milestone in the commercialisation of CFG’s CLEAN OilCell technology platform, unlocking access to the global personal care and cosmetics sector, the company said on 12 September. According to a report on the sector by Grand View Research, the industry is projected to grow from US$295.95bn in 2023 to more than US$445.98bn by 2030. The CLEANOilCell technology is a microbial/fermentation‑based platform that uses non-genetically modified (GM) oleaginous yeast grown on food waste as the carbon/nutrient source. CFG uses fermentation technology to grow the yeast in tanks similar to those used in the brewing industry.
OnScent® Launches ScentRadar™: A Generative AI Platform Redefining Fragrance Trend Forecasting
ScentRadar™ is OnScent's proprietary AI-powered market intelligence platform built to decode real-time consumer behavior and fragrance trends. Powered by a digitally native tech stack, ScentRadar generatively learns to 'smell', analyzing data streams 24/7 to build fragrances consumers are dreaming about.
SINGAPORE'S REBEE HEALTH RAISES INVESTMENT FROM 1337 VENTURES TO EXPAND DIGITAL PHYSIOTHERAPY SOLUTIONS
Singapore-based health tech firm Rebee Health has raised investment from Malaysia-based venture capital firm 1337 Ventures to expand digital physiotherapy solutions. 1337 Ventures said in a statement on Wednesday that recognizing Rebee Health’s potential to reshape rehabilitation, 1337 Ventures has invested in the startup through its 1337 Capital 1, furthering its commitment to funding disruptive technology in healthcare. With this funding, Rebee Health aims to expand its wearable rehabilitation solutions to more hospitals, clinics, and direct consumers, develop artificial intelligence (AI)-driven rehabilitation to enhance patient engagement and recovery, and strengthen data insights for remote decision-making to improve patient outcomes and reduce costs.
More
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Start a free trial chevron_right
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
DigitalMedical Open Innovation
デジタル・メディカル・オープンイノベーション
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future
of Health Care
OUR TECHNOLOGY HELPS
YOUR BUSINESS
Our technology will help your business
Technology
Does Stem Cell Culture Supernatant Affect the Skin Microbiome? Investigation Results
ReU Inc. (Headquarters: Chuo-ku, Tokyo; President: Natsuhi Ueno), which offers various services utilizing ReU Culture Medium (hereinafter referred to as “culture supernatant”), a human stem cell culture supernatant, investigated the effects of the culture supernatant—manufactured and purified at domestic partner laboratories—on the skin microbiome to verify its efficacy.
PR TIMES
Domestic startup developing plant-based egg alternatives
In recent years, the environment surrounding chicken eggs has undergone significant changes, including supply shortages and price surges due to the spread of avian influenza, as well as strengthened animal welfare regulations in regions like the EU. For manufacturers of processed egg products, such as confectionery and bakery goods, stabilizing raw material procurement and addressing sustainability have become urgent challenges. UMAMI UNITED, with its mission of “Creating the Future at ONE TABLE,” has achieved steady growth through its unique approach: providing plant-based eggs with optimized functionality tailored to the specific needs of food businesses. Since our previous investment, the company has successfully pivoted its strategy from full substitutes to function-specific products. By building a recipe library categorized by application, it has established a robust system for accumulating R&D knowledge. We have made an additional investment in this Pre-Series A round, following our seed round, to support UMAMI UNITED's egg functionality library, its ability to solve customer challenges using this library, and its potential to pioneer a sustainable food future.
PR TIMES
Solid-State Fermentation: The Technology that Turns Waste into Super Ingredients for Aquafeed
The aquaculture industry, which is essential for global food security, faces a sustainability dilemma: dependence on ingredients such as fishmeal and soya bean meal. However, in recent years, technological advancements and pioneering research breakthroughs are putting into practice a promising biotechnological solution: Solid-State Fermentation. This ancient technique, used in food like bread and beer, is being refined to transform waste inot a new ingredient of high nutritional value for fish. According to experts, Solid-State Fermentation is not only sustainable but is set to revolutionise aquafeed thanks to three specific points that make it a high-impact solution.
mispeces
An AI medical device that diagnoses COVID-19 using throat images has obtained regulatory approval.
Iris Corporation (Headquarters: Chuo-ku, Tokyo; President: Sho Okiyama; hereinafter “the Company”) announces that it has developed an AI diagnostic tool targeting COVID-19 and that this AI (hereinafter “the new feature”) received regulatory approval on October 2, 2025. This new feature is the one for which the Company submitted an approval application to the government last December*1. This press release reports that this new feature has become the first* AI medical device in Japan to receive medical device approval for diagnosing COVID-19 using throat photographs.
Aillis
Bifidobacteria in Oil: A Convenient Liquid Probiotic Supplement
・Newly launched on the Naturecan official website: Bifiora lactic acid bacteria oil ・Get your bifidobacteria in oil form! A new liquid-type probiotic supplement ・Features Bifidobacterium BB536 that ‘reaches the gut alive’ ・Unscented and tasteless for easy, refreshing daily support
PR TIMES
Functional food with skin elasticity claims using ethyl α-D-glucoside (α-EG) as the functional ingredient has been notified.
Our company has newly demonstrated that ingesting “α-EG,” a component found in Japanese sake, helps maintain the elasticity of the hands and skin in individuals experiencing age-related loss of skin elasticity. We have submitted a notification for a functional food with “α-EG” as a new functional ingredient, which was made public on October 15, 2025. Our Research Institute has long demonstrated that α-EG promotes cell proliferation and collagen production in human skin fibroblasts, and improves skin hydration and rough skin when applied topically. This time, we created a systematic review (SR) based on human oral consumption trial data conducted by an external institution and submitted the notification.
大関株式会社
Can Cultivated Marine Supplements Plug the Alt-Seafood Nutrition Gap?
Singaporean food tech startup Umami Bioworks has launched a line of cell-cultured marine supplements to address nutritional deficiencies in non-seafood consumers. Despite consumer concerns about overfishing and the environmental implications of conventional seafood, fish-free alternatives still make up just 1% of this industry. Nutrition is a major reason. Vegan and vegetarian seafood analogues tend to have a lower protein, vitamin B12, and omega-3 content, and experts have called for a diversification of sources and greater micronutrient fortification to truly build consumer uptake. For instance, most seafood alternatives that contain omega-3 fatty acids source them from alpha-linolenic acid, which converts poorly into eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
green queen
Swedish Cytely raises €3 million to make “smart microscopy” the new standard in science
Lund-based deeptech startup Cytely has raised €3 million in a round led by Ugly Duckling Ventures, with participation from existing investor Icebreaker.vc, to expand access to its smart-microscopy platform. Cytely turns ordinary microscopes into real-time data engines, eliminating manual bottlenecks and allowing labs to generate statistically powered results in minutes instead of months. Already adopted at Lund University and other leading research institutions worldwide, the platform helps scientists quantify complex cellular phenomena — from viral latency to cancer research — with unprecedented speed and accuracy. The fresh funding will be used to enhance Cytely’s intelligent acquisition tools, broaden compatibility with microscope brands, and develop one-click quantitative workflows that make data-centric discovery accessible to every lab. The company’s broader goal is to build a global discovery network where researchers can share validated methods, re-analyze datasets, and accelerate breakthroughs in human biology and disease prevention.
Arctic Startup
Next-generation ventilator featuring integrated turbine design eliminates need for air piping connections Delivers both lightweight construction and extended operating time
Nihon Kohden Corporation has launched its first turbine-driven, tracheal-intubation ventilator, the NKV-440 Series, in the domestic market. Developed and manufactured by Nihon Kohden OrangeMed in California, USA, this marks its introduction to the Japanese market following its launch in emerging markets in 2022 and the US market in 2024. This product represents one outcome of the company's mid-term management plan established in 2017, prior to the COVID-19 pandemic, which emphasized strengthening ventilator development. While inheriting the operability and functions of the “NKV-550 Series” (which received expedited approval in 2020), it adopts turbine drive technology, eliminating the need for air tubing and enabling use in environments without air supply equipment. Furthermore, its compact, lightweight design and replaceable long-duration battery allow flexible use not only in ERs and ICUs but also in general wards and for in-hospital transport. Based on the “Seamless Care” concept, it accommodates a wide range of patients from neonates (optional) to adults. It enables both invasive and non-invasive ventilation and high-flow therapy with a single unit, while also supporting lung protection strategies via the “Gentle Lung Suite” (optional). The internal turbine incorporates a HEPA filter and achieves approximately 5 hours of operation without compressed air piping. It features an intuitive UI, similar to a smartphone, enhancing operability and workflow efficiency. Priced at ¥8.14 million (including tax; ¥7.4 million before tax), the company aims to sell over 140 units within the next three years. Nihon Kohden intends to improve hospital workflows and enhance the quality of patient care through this new model, which offers high mobility without piping.
DxMedical Cloud™︎
New nanotechnology drug reduces amyloid beta in mouse brains by 50 to 60 percent
While scientists still do not know what exactly causes Alzheimer’s disease, previous research shows there are a number of potential factors. A new study explains how a research team was able to use a new nanotechnology strategy to reverse Alzheimer’s disease in mice with the condition. The new nanotechnology helped reduce amyloid-beta in the mice’s brains by 50-60%.
Medical News Today
Clean Food Group’s fermentation-derived oil approved for cosmetic use in the UK, Europe and USA
British start-up Clean Food Group (CFG)’s fermentation-derived oil has been approved for cosmetic use in the UK, Europe and the USA. The approval marked a major milestone in the commercialisation of CFG’s CLEAN OilCell technology platform, unlocking access to the global personal care and cosmetics sector, the company said on 12 September. According to a report on the sector by Grand View Research, the industry is projected to grow from US$295.95bn in 2023 to more than US$445.98bn by 2030. The CLEANOilCell technology is a microbial/fermentation‑based platform that uses non-genetically modified (GM) oleaginous yeast grown on food waste as the carbon/nutrient source. CFG uses fermentation technology to grow the yeast in tanks similar to those used in the brewing industry.
OFI
OnScent® Launches ScentRadar™: A Generative AI Platform Redefining Fragrance Trend Forecasting
ScentRadar™ is OnScent's proprietary AI-powered market intelligence platform built to decode real-time consumer behavior and fragrance trends. Powered by a digitally native tech stack, ScentRadar generatively learns to 'smell', analyzing data streams 24/7 to build fragrances consumers are dreaming about.
yahoo!finance
SINGAPORE'S REBEE HEALTH RAISES INVESTMENT FROM 1337 VENTURES TO EXPAND DIGITAL PHYSIOTHERAPY SOLUTIONS
Singapore-based health tech firm Rebee Health has raised investment from Malaysia-based venture capital firm 1337 Ventures to expand digital physiotherapy solutions. 1337 Ventures said in a statement on Wednesday that recognizing Rebee Health’s potential to reshape rehabilitation, 1337 Ventures has invested in the startup through its 1337 Capital 1, furthering its commitment to funding disruptive technology in healthcare. With this funding, Rebee Health aims to expand its wearable rehabilitation solutions to more hospitals, clinics, and direct consumers, develop artificial intelligence (AI)-driven rehabilitation to enhance patient engagement and recovery, and strengthen data insights for remote decision-making to improve patient outcomes and reduce costs.
tnglobal